How to Buy Diebold Nixdorf Stock
Diebold Nixdorf Inc
Diebold Nixdorf is a app company located in Ohio, United States, which is part of the Technology sector, and is traded under the ticker DBD on the NYSE exchange.
Diebold Nixdorf stock last closed at $65.09, down 0.31% from the previous day, and has increased 66.43% in one year. It has overperformed other stocks in the Software - Application industry by 0.89 percentage points. Diebold Nixdorf stock is currently +86.64% from its 52-week low of $34.88, and -1.8% from its 52-week high of $66.28.
At the moment, there are 35.87M DBD shares outstanding. The market cap of DBD is $2.33B. In the last 24 hours, 127,000 DBD shares were traded.
How to Buy Diebold Nixdorf Stock
Wondering how to invest in Diebold Nixdorf stock? Here's how.
- Choose where to buy Diebold Nixdorf stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you determine where to buy Diebold Nixdorf stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Pick your payment method and add your info.
- Research Diebold Nixdorf stock: The Diebold Nixdorf ticker symbol is DBD. Is Diebold Nixdorf stock a good investment? Should you buy shares of DBD? How do DBD's underlying business fundamentals look? Do top analysts think Diebold Nixdorf is a good buy? Why has DBD's stock price moved recently? (Hint: Our stock research website can help you decide if DBD is a good stock to buy).
- Execute your DBD trade: Decide if you will purchase DBD shares at the current market price or use a limit order to purchase DBD shares at a particular price.
- Get the latest news on your DBD position: Create a watchlist to important updates regarding your new investment in Diebold Nixdorf shares.
Step 1: Choose where to buy Diebold Nixdorf stock
You will need an online brokerage account in order to access the NYSE market and buy DBD shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the best brokerage, you need to fill out some personal info so you can invest in DBD today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start a new brokerage account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have created your account on a investment app, you need to deposit funds:
Watch the walkthrough below to see the process of transferring money into your new brokerage account.
Step 4: Research Diebold Nixdorf stock
Once you have chosen the best place to buy Diebold Nixdorf stock, it's crucial to evaluate their stock before you buy, so you can comprehend the risk and upside.
Diebold Nixdorf quick stats
DBD Due Diligence Score
WallStreetZen was built to help everyday investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on DBD's stock page.
How is DBD stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge DBD's true value.
Using relative valuations methods:
- DBD could be overvalued based on its P/E ratio of 46.83x, relative to Software - Application industry P/E ratio of 8.12x
- DBD could be undervalued based on its P/B ratio of 2.11x, relative to Software - Application industry P/B ratio of 6.23x
- DBD may be undervalued based on its PEG ratio of 0.61x
You can do additional valuation analysis on DBD's stock here.
How do DBD Financials look?
Positive Financial Indicators:
- DBD's operating cash flow of $279.40M allows it to safely service it's debt of $934.00M.
- There are more short-term assets than short-term liabilities on the DBD balance sheet.
- There are more short-term assets than long-term liabilities on the DBD balance sheet.
- DBD profit margin has gone up from 0% to 1.4% in the past year.
Negative Financial Indicators:
- DBD earnings of $168.10M is not sufficient to cover its interest payments.
- DBD has a relatively high debt to equity ratio of 2.36.
Is it a good time to buy Diebold Nixdorf stock, according to analysts?
Out of 3 sell side analysts who give ratings on DBD, the consensus analyst rating on DBD is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Diebold Nixdorf stock forecast page.
DBD Trading Indicators
DBD Revenue
Last year, DBD earnings were $50.60M. During the past one years, DBD's earnings have increased by 13,800% per year. This was faster than the Software - Application industry average of 125.2%.
Last year, DBD revenue was $3.69B. During the last 1 years, DBD's revenue has gone up by -2.86% per year. This was slower than the Software - Application industry average of 22.36%.
Dive into DBD's earnings and revenue performance here.
What are DBD insiders up to?
In the past year, executives and large shareholders at DBD have sold more shares than they have bought.
Millstreet Capital Management LLC, 10% Owner of DBD, was the latest DBD insider to sell. They sold $2,614,560.48 worth of DBD shares on Nov 6, 2025.
Dig into more about who owns DBD stock here.
Can I get consistent income from DBD stock?
No, Diebold Nixdorf doesn't provide an income stream by paying out dividends.
What do other traders have to say about DBD?
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your DBD trade
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact price, use a limit order.
Press the Open button and eToro will place the order.
If you want more help investing in stocks on eToro, click the how to video below:
Step 6: Get the latest news on your DBD position
Now that you own some DBD stock, you'll want to stay up-to-date on your investment.
Create a watchlist to keep tabs on your DBD stock.
DBD Feed
How to Buy Stock in Diebold Nixdorf
To reiterate, here are the 6 steps to buy Diebold Nixdorf stock:
- Choose where to buy Diebold Nixdorf stock
- Create your brokerage account
- Deposit money your brokerage account
- Research Diebold Nixdorf stock
- Execute your DBD trade
- Get the latest news on your DBD position
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to track your investment in Diebold Nixdorf, create a watchlist on WallStreetZen today.
Other Stock Buying Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.